Journal
OPEN FORUM INFECTIOUS DISEASES
Volume 3, Issue 1, Pages -Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/ofid/ofw007
Keywords
gene expression; genomic; influenza; oseltamivir
Categories
Funding
- Veteran's Affairs Medical Center [1IK2CX000611]
- Defense Advanced Research Projects Agency [lN66001-07-C-0092]
Ask authors/readers for more resources
Early, presymptomatic intervention with oseltamivir (corresponding to the onset of a published host-based genomic signature of influenza infection) resulted in decreased overall influenza symptoms (aggregate symptom scores of 23.5 vs 46.3), more rapid resolution of clinical disease (20 hours earlier), reduced viral shedding (total median tissue culture infectious dose [ TCID50] 7.4 vs 9.7), and significantly reduced expression of several inflammatory cytokines (interferon-., tumor necrosis factor-a, interleukin-6, and others). The host genomic response to influenza infection is robust and may provide the means for early detection, more timely therapeutic interventions, a meaningful reduction in clinical disease, and an effective molecular means to track response to therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available